(Q37561699)

21 August 2017

1 reference

title

Molecular pathogenesis of Parkinson disease: insights from genetic studies (English)

1 reference

21 August 2017

0 references

1 reference

1

Thomas Gasser

1 reference

21 August 2017

27 July 2009

1 reference

Expert Reviews in Molecular Medicine

21 August 2017

1 reference

21 August 2017

11

1 reference

21 August 2017

e22

1 reference

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

21 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

ATP13A2 variability in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Role of DJ-1 in Parkinson's disease

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS1462399409001148

21 January 2018

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

The PINK1/Parkin pathway regulates mitochondrial morphology

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin enhances mitochondrial biogenesis in proliferating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lewy bodies and parkinsonism in families with parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Familial juvenile parkinsonism: clinical and pathologic study in a family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The role of pathogenic DJ-1 mutations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lrrk2 and Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Roc, a Ras/GTPase domain in complex proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Linkage disequilibrium and association of MAPT H1 in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Novel PINK1 mutations in early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

PINK1 mutations are associated with sporadic early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin mutations are frequent in patients with isolated early-onset parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Distribution, type, and origin of Parkin mutations: review and case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Gro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Variation in GIGYF2 is not associated with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Clinical genetic analysis of Parkinson's disease in the Contursi kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lack of replication of association between GIGYF2 variants and Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Significant linkage of Parkinson disease to chromosome 2q36-37

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Update on the genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Parkin variants in North American Parkinson's disease: cases and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Cell systems and the toxic mechanism(s) of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Interface between tauopathies and synucleinopathies: A tale of two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Tau gene and Parkinson's disease: a case-control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Multiple regions of alpha-synuclein are associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Treatments for Parkinson disease--past achievements and current clinical needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

UCHL1 is a Parkinson's disease susceptibility gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The ubiquitin pathway in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Characterization of PLA2G6 as a locus for dystonia-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A susceptibility gene for late-onset idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Heterozygousparkinpoint mutations are as common in control subjects as in Parkinson's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Lrrk2 pathogenic substitutions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

PARK11 is not linked with Parkinson's disease in European families

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

Multiplealpha-synucleingene polymorphisms are associated with Parkinson’s disease in a Norwegian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

-Synuclein and Parkinson disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

What causes cell death in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Molecular genetic analysis of a novelParkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in theParkin gene in affected individuals

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

The role of alpha-synuclein and tau in neurodegenerative movement disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Filamentous nerve cell inclusions in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001148

7 January 2021

10.1017/S1462399409001148

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19631006